Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02912767 · ClinicalTrials.gov registry record
Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 625
- Enrollment target
NCT02912767: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT02912767 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 625 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02912767 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 625 participants
- Enrollment target
Study Summary
The investigators are interested in understanding how the patient has been doing since their surgery for endometrial cancer and if they are experiencing any symptoms related to lymphedema (swelling) in the your lower body. The investigators hope that information from the patient and others will help them improve care for women treated for endometrial cancer.
Primary Outcome
Data from respondents will be analyzed to determine prevalence of patient reported lymphedema overall; these will then be compared to the prevalence among those who underwent SLN mapping alone, or a comprehensive pelvic lymphadenectomy (+/- para-aortic LND and +/-SLN mapping in conjunction).
Interventions
- BEHAVIORAL questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 625 participants |
| Start Date | 2016-07-20 |
| Est. Completion | 2020-06-01 |
What the finished NCT02912767 record still lists
NCT02912767 is an observational study that tracks outcomes without assigning an intervention. The registered 625 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which questionnaire is the first listed.
NCT02912767 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02912767 about?
NCT02912767 is a clinical study titled "Prevalence of Self Reported Lymphedema in Patients With Endometrial Cancer". The investigators are interested in understanding how the patient has been doing since their surgery for endometrial cancer and if they are experiencing any symptoms related to lymphedema (swelling) in the your lower body. The investigators hope that information from the patient and others will help...
What is the current status of trial NCT02912767?
This trial is currently completed. The enrollment target is 625 participants. The study started on 2016-07-20. Estimated completion is 2020-06-01.
What interventions are being tested in trial NCT02912767?
The interventions under investigation include: questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT02912767?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05349227 · 625 participants · NA
Comprehensive Outcomes for After Cancer Health
- NCT06103864 · 625 participants · Phase 3
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer
- NCT06230510 · 625 participants · NA
Milk-Tot Study: Impact of Whole Versus Low-fat Milk on Child Health
- NCT06677112 · 625 participants · NA
MCC-24-GYN-11: Comparison of Nodal Sampling in Endometrial Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI